Chemgenex【CXSP】銘柄情報

Chemgenex Pharmaceuticals Ltd (MM) (CXSP) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

16.00

( - )

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

前日終値

16.00

始値

時刻

最終取引時間

平均取引量 (3 か月)

財務取引量

VWAP

Pivotal Study Results: ChemGenex’s Omacetaxine May Provide the First Viable Drug Treatment Option for Patients With a Highl...

ChemGenex Pharmaceuticals Limited (ChemGenex) (ASX:CXS) (NASDAQ:CXSP) announced that the latest data from its pivotal study of...

ChemGenex’s Omacetaxine to be Showcased in Three Oral Presentations at EHA

ChemGenex Pharmaceuticals Limited (ASX:CXS) (NASDAQ:CXSP) announced today that new data from two clinical studies and one...

ChemGenex to Present Pivotal Data in T315I Positive CML Patients as Oral Presentation at ASCO

ChemGenex Pharmaceuticals Limited (ASX:CXS) (NASDAQ:CXSP) announced today that updated clinical data from the...

ChemGenex Completes Capital Raising, Announces Rights Issue

ChemGenex Pharmaceuticals Limited (ChemGenex) (ASX:CXS) (NASDAQ:CXSP) is pleased to announce the successful completion of a...

New Data Suggesting that ChemGenex’s Omacetaxine Can Eradicate Leukemic Stem Cells May Offer a Breakthrough in Treating CML

Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous...

ChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients

ChemGenex Pharmaceuticals (ASX:CXS)(NASDAQ:CXSP) has announced interim results from its ongoing phase 2/3 trial of omacetaxine...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CXSP - Frequently Asked Questions (FAQ)

What is the current Chemgenex Pharmaceuticals Ltd (MM) share price?

The current share price of Chemgenex Pharmaceuticals Ltd (MM) is US$ 16.00

What is the 1 year trading range for Chemgenex Pharmaceuticals Ltd (MM) share price?

Chemgenex Pharmaceuticals Ltd (MM) has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Slojab 1分前

Yes.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177620062

ZYLM

Troubles1 1分前

Hey Chen go look at LinkedIn now

TGLO

georgie18 2分前

RPGL...$3.91...🥳...

RPGL

Cavemanug 2分前

Why would you hope this doesn't hit $1 today...im most likely wrong but hoping for negative stock movement solely for the purpose of being right about a reverse split the is NEVER GOING TO HAPPEN is just completely asinine

TGLO

georgie18 2分前

RPGL...$3.91...🥳...

RPGL

AKFish 2分前

Looking fwd to DOLLAR LAND!

PDIV

somberfox 2分前

We deflated actually

CLNV

ProfitChaser 3分前

Added some 0015 today

TIMGZ 3分前

STI, you hear that right , from $5 to $38.15 so far, SPACE X EFFECT, stay tuned for more

STI

Slojab 3分前

For every time it's "worked", I've seen it mean absolutely nothing thousands of times.

But explain how you think it happened. Someone sitting at their desk gets a phone call? They're told a shitty little OTC ticker is going to put out a worthless press release and they think they'd be

QEDN

vlispxpert 3分前

Account nice & green today ;)

1manband 3分前

Tire giant Pirelli vows legal action as short seller alleges ‘close relationship’ with Russia

https://www.cnbc.com/2026/06/04/pirelli-grizzly-research-russia-legal-action.html

Italian tire maker Pirelli has instructed lawyers to take legal action against Grizzly Researc

MRMOWMAN 3分前

Did't Fill All $.05's Want Me to Chase , Just Filled!!!

EVLI

Helter Skelter 3分前

Profit takers, nothing wrong with that, SHORTS fighting it, and humiliated "expert" "analysts" 😜 JMO

$BB 10.43 again...up down...

ORCA 3分前

SOMETHING IS NOT RIGHT HERE.THE SAME GUY WAS OFFERING 2 MILLION AGAIN AT .009.

BCDS

i_like_bb_stock 3分前

news took some no notes low float a dream in the otc https://finance.yahoo.com/sectors/technology/articles/ladybug-group-inc-unveils-proprietary-134000311.html

LBRG

Gold prospector 4分前

.01 here we come!!!! 🎊🎈🎉💰💰💰

CCLX

Lemmiwinks 4分前

Decision out. Appeals ruling reversed. Case remanded.

AMRN

georgie18 4分前

WGRX...$4.27...🥳...Post Split Reversing nicely...

georgie18

Re: georgie18 post# 131

Thursday, May 28, 2026 9:23:40 AM

Post#
143
of 144
WGRX...$3.95...🥳...Post Split...Zero shares to borrow...Another R

WGRX

pennylandspirit 4分前

I MIGHT BUY A FEW MORE AT THIS PRICE FOR SURE

EVLI

wiwineguy 4分前

"Visually efficient". How diplomatic.Lol.

TGLO

georgie18 4分前

WGRX

i_like_bb_stock 4分前

$lbrg news took some no notes low float a dream in the otc https://finance.yahoo.com/sectors/technology/articles/ladybug-group-inc-unveils-proprietary-134000311.html

LBRG

Monroe1 4分前

Go Dr. Pestell, He just secured a 2.5 M $ grant to fight breast cancer resistance.
https://lnkd.in/dZGVnAqc

CYDY

i_like_bb_stock 4分前

$lbrg news took some no notes low float a dream in the otc https://finance.yahoo.com/sectors/technology/articles/ladybug-group-inc-unveils-proprietary-134000311.html

LBRG

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Chemgenex Pharmaceuticals Ltd (MM) (CXSP)

Chemgenex Pharmaceuticals Ltd (MM) (CXSP) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

CXSP 最新ニュース

Pivotal Study Results: ChemGenex’s Omacetaxine May Provide the First Viable Drug Treatment Option for Patients With a Highl...

ChemGenex’s Omacetaxine to be Showcased in Three Oral Presentations at EHA

ChemGenex to Present Pivotal Data in T315I Positive CML Patients as Oral Presentation at ASCO

ChemGenex Completes Capital Raising, Announces Rights Issue

New Data Suggesting that ChemGenex’s Omacetaxine Can Eradicate Leukemic Stem Cells May Offer a Breakthrough in Treating CML

ChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients

ChemGenex Announces Publication Confirming Activity of Ceflatonin(R) in T315I-Positive CML

ChemGenex Announces the Completion of A$21 Million Financing

ChemGenex Pharmaceuticals: Announcement Pursuant To Nasdaq Marketplace Rule 4350(b)

Preclinical Progress Reported at American Association of Cancer Research Conference

CXSP - Frequently Asked Questions (FAQ)

CXSP 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Chemgenex Pharmaceuticals Ltd (MM) (CXSP)

Chemgenex Pharmaceuticals Ltd (MM) (CXSP) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

CXSP 最新ニュース

Pivotal Study Results: ChemGenex’s Omacetaxine May Provide the First Viable Drug Treatment Option for Patients With a Highl...

ChemGenex’s Omacetaxine to be Showcased in Three Oral Presentations at EHA

ChemGenex to Present Pivotal Data in T315I Positive CML Patients as Oral Presentation at ASCO

ChemGenex Completes Capital Raising, Announces Rights Issue

New Data Suggesting that ChemGenex’s Omacetaxine Can Eradicate Leukemic Stem Cells May Offer a Breakthrough in Treating CML

ChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients

ChemGenex Announces Publication Confirming Activity of Ceflatonin(R) in T315I-Positive CML

ChemGenex Announces the Completion of A$21 Million Financing

ChemGenex Pharmaceuticals: Announcement Pursuant To Nasdaq Marketplace Rule 4350(b)

Preclinical Progress Reported at American Association of Cancer Research Conference

CXSP - Frequently Asked Questions (FAQ)

CXSP 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS